Voting Results and Scrutinizer’s Report of Vijaya Diagnostic Centre Ltd. Equity Shareholders Meeting
K N Mishra
28/Apr/2025
What's covered under the Article:
-
Consolidated voting results for Vijaya Diagnostic Centre Ltd.'s shareholders meeting held on April 25, 2025.
-
Approval of the Scheme of Amalgamation with Medinova Diagnostic Services Limited.
-
Scrutinizer’s report and details on votes cast by public and promoter shareholders.
Vijaya Diagnostic Centre Limited, a leading diagnostic service provider, held its meeting of equity shareholders on April 25, 2025, pursuant to the order of the Hon'ble National Company Law Tribunal (NCLT), Hyderabad Bench. The meeting was conducted via Video Conference (VC) and Other Audio Visual Means (OAVM), as mandated by the Tribunal in its order dated March 5, 2025.
The purpose of the meeting was to seek approval for the Scheme of Amalgamation between Medinova Diagnostic Services Limited (Transferor Company) and Vijaya Diagnostic Centre Limited (Transferee Company). The Scheme was presented for approval under Sections 230 to 232 of the Companies Act, 2013, with both the shareholders and creditors of the companies involved.
Voting Results Overview:
The voting process included remote e-voting and e-voting at the meeting, as per the guidelines set out by the Securities and Exchange Board of India (SEBI). A total of 65,418 shareholders were eligible to vote, with 56 shareholders attending the meeting via video conferencing.
Promoter and Promoter Group Voting:
The promoter group, which holds 5,44,52,053 shares, participated actively in the voting process. Out of this, 99.92% of the votes were cast in favor of the resolution, with no votes against. This demonstrated overwhelming support from the promoter group for the amalgamation scheme.
Public Institutional Shareholder Voting:
Public institutional shareholders, holding 4,42,49,621 shares, also showed strong support for the resolution, with 95.35% of the votes cast in favor. Once again, no votes were recorded against the proposal.
Public Non-Institutional Shareholder Voting:
Public non-institutional shareholders, who held 39,34,604 shares, showed a mixed response, with 99.93% of the votes cast in favor of the resolution. A small fraction, 0.07%, was against the scheme.
Scrutinizer’s Report:
The Scrutinizer’s Report, prepared by CS M.V. Padmaja Kalyani, confirms the results of the voting process. As per the report, the total number of votes cast in favor of the resolution was 9,66,76,952, representing 94.19% of the total outstanding shares. No invalid votes were recorded during the process, ensuring the transparency and fairness of the vote.
The resolution was passed with the requisite majority, with a clear approval of the proposed amalgamation scheme. The report is accessible on the company’s official website and the KFintech e-voting platform.
This voting outcome underscores strong shareholder confidence in the future growth and synergies expected from the amalgamation between Vijaya Diagnostic Centre Limited and Medinova Diagnostic Services Limited, promising improved service capabilities and expanded market reach.
For full details on the voting results and the Scrutinizer’s Report, shareholders can visit Vijaya Diagnostic Centre’s official website and KFintech’s e-voting portal.
This approval marks a significant milestone in the corporate restructuring of Vijaya Diagnostic Centre Limited and aligns with their strategic goals to enhance operational efficiencies and expand their diagnostic network.
The Upcoming IPOs in this week and coming weeks are Arunaya Organics,Kenrik Industries,Wagons Learning,Srigee DLM.
The Current active IPO are Ather Energy, Iware Supplychain Services.
Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.
Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.
Related News
Disclaimer
The information provided on this website is for educational and informational purposes only and should not be considered as financial advice, investment advice, or trading recommendations.
Trading in stocks, forex, commodities, cryptocurrencies, or any other financial instruments involves high risk and may not be suitable for all investors. Prices can fluctuate rapidly, and there is a possibility of losing part or all of your invested capital.
We do not guarantee any profits, returns, or outcomes from the use of our website, services, or tools. Past performance is not indicative of future results.You are solely responsible for your investment and trading decisions. Before making any financial commitment, it is strongly recommended to consult with a qualified financial advisor or do your own research.
By accessing or using this website, you acknowledge that you have read, understood, and agree to this disclaimer. The website owners, partners, or affiliates shall not be held liable for any direct or indirect loss or damage arising from the use of information, tools, or services provided here.